http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0160910-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 1985-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b92f2b95300101f155294eb099c73496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1968f19e2ac62dd72b2215b28eef05d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d160756efde62629ed6c5c89c786507 |
| publicationDate | 1985-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0160910-A2 |
| titleOfInvention | 7-Deazapurine derivatives and their production |
| abstract | 7-Deazapurine derivatives of the formula:wherein R' is phenyl which has, at the ortho position and/or para position as substituents, at least one group represented by the formula -O-R<sup>3</sup>, -S-R<sup>4</sup> or -N <sup>R5</sup> (wherein R<sup>3</sup>, R<sup>4</sup>, R<sup>5</sup><sub>R</sub><sup>6</sup> and R<sup>6</sup> are the same or different and each is hydrogen or an alkyl or phenyl group which may be substituted, whereby R<sup>5</sup> and R<sup>6</sup>, together with the adjacent nitrogen atom, may form a cyclic amino group which may be substituted, and R<sup>3</sup>, R<sup>4</sup>, R<sup>5</sup> and R<sup>6</sup> each may represent a protective group), and may have a group or groups with a molecular weight of up to about 200 as a substituent at any position other than those having the said substituents introduced; R<sup>2</sup> is an amino group which may be protected, or its salt, have a potent antitumor activity, and hence the compounds are useful as an antitumor agent. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0831829-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6395733-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0831829-A1 |
| priorityDate | 1984-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1298.